VIDEO: Gordon Gochenauer on ASCO 2018

In this 2 part series, Psyma's Oncology Practice Lead, Gordon Gochenauer, shared his thoughts in anticipation of the ASCO 2018 conference, particularly on the anticipated keynotes in immuno-oncology for non-small cell lung cancer, as well the future of immunotherapy combinations based on recent IDO trials results to be presented at ASCO 2018.

PART 1:

PART 2: